ShRNA-mediated silencing of ANXA1 suppresses nuclear factor (NF)-kB activity, which results in the direct inhibition of CXCR4 and matrix metalloproteinase (MMP) expression, impeding tumor cell invasion [54]. This evidence concerns the gene CXCR4 and neoplasm.